Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics, data management, biostatistics, medical writing and publishing. He also oversees clinical monitoring and project management in the US.
Sanjay comes to us fresh from a stint as Global Director of Biostatistics, Data Management (Opioid Addiction and Schizophrenia) at Reckitt Benckiser in Virginia.
In over twenty-three years of experience as a lead statistician in the US, Canada, Europe and Asia, Mr. Mitter has held notable industry positions at Allergan, Novella Clinical (a Quintiles Company), PRA International, Regeneron, Roche, Pharmacia, Sanofi Pasteur, and Ciba-Geigy.
Working in Clinical Biostatistics, Data Management and Statistical Programming (R&D), including representing the sponsor company to the FDA/EMA/cFDA and other regulatory agency meetings, Sanjay has accomplished numerous approvals. These include: Sanofi Pasteur’s pediatric DPT vaccine DAPTACEL®/PENTACEL®; Pharmacia’s antihypertensive INSPRA®; Roche’s fat blocker XENICAL®; Reckitt Benckiser’s opioid partial agonist (SUBUTEX®/ SUBUXONE®); and Allergan’s medical weight loss device LAPBAND®.
By bringing Sanjay on board, QPS has ratcheted our Clinical Research Services capabilities up another notch. Sanjay, we’re really glad to have you!